Capecitabine — 150MG, Film-coated tablet, bottle of 60 tablets

Capecitabine — 150MG, Film-coated tablet, bottle of 60 tablets

Capecitabine is a film-coated tablet for oral use. Capecitabine tablets are a nucleoside metabolic inhibitor indicated for: Colorectal Cancer adjuvant treatment of patients with Stage III colon cancer as a single agent or as a component of a combination chemotherapy regimen. ( 1.1 ) perioperative treatment of adults with locally advanced rectal cancer as a component of chemoradiotherapy. ( 1.1 ) treatment of patients with unresectable or metastatic colorectal cancer as a single agent or as a component of a combination chemotherapy regimen. ( 1.1 ) Breast Cancer treatment of patients with advanced or metastatic breast cancer as a single agent if an anthracycline- or taxane-containing chemotherapy is not indicated. ( 1.2 ) treatment of patients with advanced or metastatic breast cancer in combination with docetaxel after disease progression on prior anthracycline-containing chemotherapy. ( 1.2 ) Gastric, Esophageal, or Gastroesophageal Jun

• Active ingredient or product type: CAPECITABINE
• Strength/concentration: 150MG
• Dosage form and route: Film-coated tablet, Oral
• Exact package presentation: bottle of 60 tablets
• NDC/item number: 67877-458-60
• Manufacturer: ASCEND LABORATORIES
• Storage/handling: Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
• Status: Rx only

Important safety information: Cardiotoxicity : May be more common in patients with a prior history of coronary artery disease.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.